Paul Greengard in News-Medical.net Blocking the dopamine D1 receptor is not a treatment option for L-DOPA-induced side effects, since it would diminish the therapeutic efficiency of L-DOPA,says Greengard, who is Vincent Astor Professor and head of the Laboratory of Molecular...